DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Voclosporin is an investigational drug.
There have been 17 clinical trials for Voclosporin. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2011.
The most common disease conditions in clinical trials are Nephritis, Lupus Nephritis, and Keratoconjunctivitis Sicca. The leading clinical trial sponsors are Aurinia Pharmaceuticals Inc., Lux Biosciences, Inc., and Leiden University Medical Center.
Recent Clinical Trials for Voclosporin
|Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients||Aurinia Pharmaceuticals Inc.||Phase 2|
|Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients||Leiden University Medical Center||Phase 2|
|Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome||Aurinia Pharmaceuticals Inc.||Phase 2/Phase 3|